Back to results

6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old (VESTRI)

Primary Purpose

Asthma

Status

Completed

Phase

Phase 4

Locations

International

Study Type

Interventional

Intervention

ADVAIR 100/50mcg

ADVAIR 250/50mcg

FLOVENT 100mcg

FLOVENT 250mcg

About this trial

This is an interventional treatment trial for Asthma focused on measuring pediatric, ADVAIR, FLOVENT, asthma

Eligibility Criteria

4 Years - 11 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Consent to participate in the study
Age 4-11 years old
Male or eligible female - Female subjects should not be enrolled if they are pregnant, lactating or plan to become pregnant during the time of study participation
Asthma diagnosis for at least 6 months
Ability to answer questions regarding asthma control and use a metered dose inhaler and DISKUS
A history of clinical varicella infection or recipient of a varicella vaccine in countries where the product label includes a warning regarding more serious chickenpox infections in patients using corticosteroids.
History of at least once occurrence of asthma exacerbation within the prior 12 months
Currently being treated for asthma and no change in asthma therapy for the last 4 weeks (Eligible subjects include: subjects with use of short-acting beta-agonist, leukotriene receptor antagonist, theophylline, or cromolyn whose asthma is not well-controlled; subjects on low-dose ICS monotherapy whose asthma is not well-controlled; subjects on low-dose ICS and one or more adjunctive therapy whose asthma is either controlled or not well-controlled asthma; subjects on medium-dose ICS monotherapy whose asthma is either controlled or not well-controlled; and subjects on medium-dose ICS and one or more adjunctive therapy whose asthma is well-controlled)

Exclusion Criteria:

History of life-threatening asthma
Unstable asthma
Current use of high-dose ICS or ICS/LABA therapy to treat asthma symptoms
Concurrent respiratory disease: Current evidence of pneumonia, pneumothorax, atelectasis, pulmonary fibrotic disease, allergic bronchopulmonary aspergillosis, cystic fibrosis, bronchopulmonary dysplasia, or other severe respiratory abnormalities other than asthma.
Respiratory infection
Subjects with only exercise-induced asthma
An asthma exacerbation within the last 4 weeks or more than 4 separate exacerbations in the last 12 months
Hospitalization for asthma within 4 weeks or more than 2 hospitalizations within the last 12 months
Other current evidence of clinically significant uncontrolled disease/conditions of any body or organ system
Neurological or psychiatric disease or history of drug or alcohol abuse of a subject or his/her guardian which in the opinion of the investigator could interfere with the subject's proper completion of the protocol requirements
Participation in an interventional study or used any investigational drug for any disease state within the last 30 days
Any adverse reaction including immediate or delayed hypersensitivity to any beta-agonist, sympathomimetic drug, or any intranasal, inhaled, or systemic corticosteroid therapy, or vehicle contained within these medication
Severe hypersensitivity to cow's milk proteins
Administration of prescription or over the counter medications that would significantly affect the course of asthma, or interact with sympathomimetic amines such as: anti-IgE (omalizumab), anticonvulsants (barbiturates, hydantoins, carbamazepine); polycyclic antidepressants, beta-adrenergic blockers; phenothiazines, monoamine oxidase inhibitors, or diuretics
Potent cytochrome P450 3A4 (CYP3A4) inhibitors within the last 4 weeks (e.g., ritonavir, ketoconazole, itraconzole)
Affiliation with investigator's site, including a immediate family member of the participating investigator, sub-investigator, study coordinator, or employee of the participating investigator.
A Child in Care (CiC) is a child who has been placed under the control or protection of an agency, organisation, institution or entity by the courts, the government or a government body, acting in accordance with powers conferred on them by law or regulation.

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Active Comparator

Arm Label

ADVAIR 100/50mcg

ADVAIR 250/50mcg

FLOVENT 100mcg

FLOVENT 250mcg

Arm Description

fluticasone propionate/salmeterol combination (100/50mcg) twice daily (AM and PM) for 6 months

fluticasone propionate/salmeterol combination (250/50mcg) twice daily (AM and PM) for 6 months

fluticasone propionate (100) twice daily (AM and PM) for 6 months

fluticasone propionate (250mcg) twice daily (AM and PM) for 6 months

Outcomes

Primary Outcome Measures

Number of Participants Experiencing an Event in the Composite Safety Endpoint of Serious Asthma Outcomes ( Asthma-related Hospitalization, Asthma-related Endotracheal Intubation, or Asthma-related Death)

Composite endpoint was defined as clinically relevant endpoint that is constructed from combinations of other clinically relevant endpoints of serious asthma outcomes (i.e., asthma-related hospitalization, asthma-related endotracheal intubation, or asthma-related death). Hospitalization was defined as an inpatient stay or a >=24-hour stay in an observation area in an emergency department or other equivalent facility. Time to first event in the composite endpoint of serious asthma-related outcomes over the 6-month study treatment period was analyzed using a Cox proportional hazards regression model. An estimate of absolute risk difference and its corresponding 95% confidence interval (CI) were also included. The Intent-to-Treat (ITT) Population included all participants randomized to study drug and who took study treatment.

Number of Participants With at Least One Asthma Exacerbation Over the 6-month Study Treatment Period

Number of participants with asthma exacerbation over the 6-month study treatment period are presented. Participants from mITT population with screening childhood asthma control test (C-ACT) scores of 20 or higher, one exacerbation in the previous year, and either low-dose inhaled corticosteroid (ICS) + one or more adjunctive therapy or medium-dose ICS monotherapy or medium-dose ICS and one or more adjunctive therapy as prior asthma therapy were included for this endpoint. Time to first exacerbation analyzed using a cox proportional hazards regression model. The number of asthma exacerbations were compared between treatments using a negative binomial regression model. The modified Intent-to-Treat (mITT) Population consisted of the ITT participants with a different data cut-off for supportive analyses of the primary composite safety endpoint.

Secondary Outcome Measures

Number of Participants Experiencing Asthma-related Deaths Over the 6-month Study Treatment Period.

Number of participants experiencing asthma-related death over the 6-month study treatment period are presented.

Number of Participants Experiencing Asthma-related Endotracheal Intubations Over the 6-month Study Treatment Period

Intubation is defined as endotracheal intubation with ventilation (mechanical or by hand). The number of participants experiencing asthma-related endotracheal intubations over the 6-month study treatment period are presented.

Number of Participants Experiencing Asthma-related Hospitalizations Over the 6-month Study Treatment Period

Hospitalization is defined as a >=24-hour stay as an inpatient or in an observation ward. The number of participants experiencing asthma-related hospitalizations over the 6-month study treatment period are presented.

Number of Participants Withdrawn From Study Treatment Due to Asthma Exacerbation Over the 6-month Study Treatment Period

An exacerbation is defined as deterioration of asthma requiring the use of systemic corticosteroids (tablets, suspension, or injection) for at least 3 days (up to 10 days) or a single depot corticosteroid injection. Number of participants experiencing at least one exacerbation from mITT population were included for this endpoint. The number of participants withdrawn from study treatment due to asthma exacerbation over the 6-month study treatment period are presented.

Percentage of Rescue-free Days Over the 6-month Study Treatment Period

Rescue-free days were days without use of rescue albuterol/salbutamol (other than pre-exercise treatment) over the 6-month study treatment period. The mean percentages of rescue-free days over the months 1-6 (defined as treatment days 2-182) are summarized. Number of participants over treatment days 2-182 from mITT Population were included for this endpoint.

Percentage of Asthma Control Days Over the 6-month Study Treatment Period

An asthma control day is one on which rescue albuterol/salbutamol use was recorded as 0, no night time awakenings were recorded, no asthma exacerbations were recorded, no work, school, or daycare days were missed by caregiver or participant due to asthma, coughing symptom score was <=1 and wheezing symptom score was 0. The mean percentages of asthma control days over the months 1-6 (defined as treatment days 2-182) are summarized. Number of participants over treatment days 2-182 from mITT Population were included for this endpoint.

Full Information

NCT ID

NCT01462344

First Posted

October 27, 2011

Last Updated

August 2, 2018

Sponsor

GlaxoSmithKline

Collaborators

Parexel

1. Study Identification

Unique Protocol Identification Number

NCT01462344

Brief Title

6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old

Acronym

VESTRI

Official Title

A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma

Study Type

Interventional

2. Study Status

Record Verification Date

August 2018

Overall Recruitment Status

Completed

Study Start Date

November 17, 2011 (undefined)

Primary Completion Date

November 1, 2015 (Actual)

Study Completion Date

November 3, 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title

Sponsor

Name of the Sponsor

GlaxoSmithKline

Collaborators

Parexel

4. Oversight

Data Monitoring Committee

Yes

5. Study Description

Brief Summary

The purpose of this study is to assess whether the risk of serious asthma-related events (asthma-related hospitalizations, endotracheal intubations, and deaths) in children 4-11 years old taking inhaled fluticasone propionate/salmeterol combination is the same as those taking inhaled fluticasone propionate alone.

Detailed Description

Progress of Enrollment, Updated Annually: This study has been completed and the final clinical study report was submitted to the FDA in May of 2016. This is the final update, as this study is complete.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Asthma

Keywords

pediatric, ADVAIR, FLOVENT, asthma

7. Study Design

Primary Purpose

Treatment

Study Phase

Phase 4

Interventional Study Model

Parallel Assignment

Masking

ParticipantCare ProviderInvestigatorOutcomes Assessor

Allocation

Randomized

Enrollment

6250 (Actual)

8. Arms, Groups, and Interventions

Arm Title

ADVAIR 100/50mcg

Arm Type

Experimental

Arm Description

fluticasone propionate/salmeterol combination (100/50mcg) twice daily (AM and PM) for 6 months

Arm Title

ADVAIR 250/50mcg

Arm Type

Experimental

Arm Description

fluticasone propionate/salmeterol combination (250/50mcg) twice daily (AM and PM) for 6 months

Arm Title

FLOVENT 100mcg

Arm Type

Active Comparator

Arm Description

fluticasone propionate (100) twice daily (AM and PM) for 6 months

Arm Title

FLOVENT 250mcg

Arm Type

Active Comparator

Arm Description

fluticasone propionate (250mcg) twice daily (AM and PM) for 6 months

Intervention Type

Drug

Intervention Name(s)

ADVAIR 100/50mcg

Other Intervention Name(s)

FSC 100/50

Intervention Description

fluticasone propionate/salmeterol combination (100/50mcg) twice daily (AM and PM) for 6 months

Intervention Type

Drug

Intervention Name(s)

ADVAIR 250/50mcg

Other Intervention Name(s)

FSC 250/50

Intervention Description

fluticasone propionate/salmeterol combination (250/50mcg) twice daily (AM and PM) for 6 months

Intervention Type

Drug

Intervention Name(s)

FLOVENT 100mcg

Other Intervention Name(s)

FP 100

Intervention Description

fluticasone propionate (100) twice daily (AM and PM) for 6 months

Intervention Type

Drug

Intervention Name(s)

FLOVENT 250mcg

Other Intervention Name(s)

FP 250

Intervention Description

fluticasone propionate (250mcg) twice daily (AM and PM) for 6 months

Primary Outcome Measure Information:

Title

Description

Time Frame

From Day 1 up to 6 months

Title

Number of Participants With at Least One Asthma Exacerbation Over the 6-month Study Treatment Period

Description

Time Frame

From Day 1 up to 6 months

Secondary Outcome Measure Information:

Title

Number of Participants Experiencing Asthma-related Deaths Over the 6-month Study Treatment Period.

Description

Number of participants experiencing asthma-related death over the 6-month study treatment period are presented.

Time Frame

From Day 1 up to 6 months

Title

Number of Participants Experiencing Asthma-related Endotracheal Intubations Over the 6-month Study Treatment Period

Description

Time Frame

From Day 1 up to 6 months

Title

Number of Participants Experiencing Asthma-related Hospitalizations Over the 6-month Study Treatment Period

Description

Time Frame

From Day 1 up to 6 months

Title

Number of Participants Withdrawn From Study Treatment Due to Asthma Exacerbation Over the 6-month Study Treatment Period

Description

Time Frame

From Day 1 up to 6 months

Title

Percentage of Rescue-free Days Over the 6-month Study Treatment Period

Description

Time Frame

From Day 1 up to 6 months

Title

Percentage of Asthma Control Days Over the 6-month Study Treatment Period

Description

Time Frame

From Day 1 up to 6 months

10. Eligibility

Sex

All

Minimum Age & Unit of Time

4 Years

Maximum Age & Unit of Time

11 Years

Accepts Healthy Volunteers

Eligibility Criteria

Inclusion Criteria: Consent to participate in the study Age 4-11 years old Male or eligible female - Female subjects should not be enrolled if they are pregnant, lactating or plan to become pregnant during the time of study participation Asthma diagnosis for at least 6 months Ability to answer questions regarding asthma control and use a metered dose inhaler and DISKUS A history of clinical varicella infection or recipient of a varicella vaccine in countries where the product label includes a warning regarding more serious chickenpox infections in patients using corticosteroids. History of at least once occurrence of asthma exacerbation within the prior 12 months Currently being treated for asthma and no change in asthma therapy for the last 4 weeks (Eligible subjects include: subjects with use of short-acting beta-agonist, leukotriene receptor antagonist, theophylline, or cromolyn whose asthma is not well-controlled; subjects on low-dose ICS monotherapy whose asthma is not well-controlled; subjects on low-dose ICS and one or more adjunctive therapy whose asthma is either controlled or not well-controlled asthma; subjects on medium-dose ICS monotherapy whose asthma is either controlled or not well-controlled; and subjects on medium-dose ICS and one or more adjunctive therapy whose asthma is well-controlled) Exclusion Criteria: History of life-threatening asthma Unstable asthma Current use of high-dose ICS or ICS/LABA therapy to treat asthma symptoms Concurrent respiratory disease: Current evidence of pneumonia, pneumothorax, atelectasis, pulmonary fibrotic disease, allergic bronchopulmonary aspergillosis, cystic fibrosis, bronchopulmonary dysplasia, or other severe respiratory abnormalities other than asthma. Respiratory infection Subjects with only exercise-induced asthma An asthma exacerbation within the last 4 weeks or more than 4 separate exacerbations in the last 12 months Hospitalization for asthma within 4 weeks or more than 2 hospitalizations within the last 12 months Other current evidence of clinically significant uncontrolled disease/conditions of any body or organ system Neurological or psychiatric disease or history of drug or alcohol abuse of a subject or his/her guardian which in the opinion of the investigator could interfere with the subject's proper completion of the protocol requirements Participation in an interventional study or used any investigational drug for any disease state within the last 30 days Any adverse reaction including immediate or delayed hypersensitivity to any beta-agonist, sympathomimetic drug, or any intranasal, inhaled, or systemic corticosteroid therapy, or vehicle contained within these medication Severe hypersensitivity to cow's milk proteins Administration of prescription or over the counter medications that would significantly affect the course of asthma, or interact with sympathomimetic amines such as: anti-IgE (omalizumab), anticonvulsants (barbiturates, hydantoins, carbamazepine); polycyclic antidepressants, beta-adrenergic blockers; phenothiazines, monoamine oxidase inhibitors, or diuretics Potent cytochrome P450 3A4 (CYP3A4) inhibitors within the last 4 weeks (e.g., ritonavir, ketoconazole, itraconzole) Affiliation with investigator's site, including a immediate family member of the participating investigator, sub-investigator, study coordinator, or employee of the participating investigator. A Child in Care (CiC) is a child who has been placed under the control or protection of an agency, organisation, institution or entity by the courts, the government or a government body, acting in accordance with powers conferred on them by law or regulation.

Overall Study Officials:

First Name & Middle Initial & Last Name & Degree

GSK Clinical Trials

Organizational Affiliation

GlaxoSmithKline

Official's Role

Study Director

Facility Information:

Facility Name

GSK Investigational Site

City

Birmingham

State/Province

Alabama

ZIP/Postal Code

35209

Country

United States

Facility Name

GSK Investigational Site

City

Birmingham

State/Province

Alabama

ZIP/Postal Code

35233

Country

United States

Facility Name

GSK Investigational Site

City

Mobile

State/Province

Alabama

ZIP/Postal Code

36608

Country

United States

Facility Name

GSK Investigational Site

City

Montgomery

State/Province

Alabama

ZIP/Postal Code

36109

Country

United States

Facility Name

GSK Investigational Site

City

Scottsboro

State/Province

Alabama

ZIP/Postal Code

35768

Country

United States

Facility Name

GSK Investigational Site

City

Toney

State/Province

Alabama

ZIP/Postal Code

35773

Country

United States

Facility Name

GSK Investigational Site

City

Tuscaloosa

State/Province

Alabama

ZIP/Postal Code

35401

Country

United States

Facility Name

GSK Investigational Site

City

Dothan

State/Province

Alaska

ZIP/Postal Code

36305

Country

United States

Facility Name

GSK Investigational Site

City

Chandler

State/Province

Arizona

ZIP/Postal Code

85224

Country

United States

Facility Name

GSK Investigational Site

City

Phoenix

State/Province

Arizona

ZIP/Postal Code

85020

Country

United States

Facility Name

GSK Investigational Site

City

Scottsdale

State/Province

Arizona

ZIP/Postal Code

85255

Country

United States

Facility Name

GSK Investigational Site

City

Scottsdale

State/Province

Arizona

ZIP/Postal Code

85288

Country

United States

Facility Name

GSK Investigational Site

City

Tucson

State/Province

Arizona

ZIP/Postal Code

85724-5073

Country

United States

Facility Name

GSK Investigational Site

City

Tucson

State/Province

Arizona

ZIP/Postal Code

85741

Country

United States

Facility Name

GSK Investigational Site

City

Bentonville

State/Province

Arkansas

ZIP/Postal Code

72712

Country

United States

Facility Name

GSK Investigational Site

City

Little Rock

State/Province

Arkansas

ZIP/Postal Code

72204

Country

United States

Facility Name

GSK Investigational Site

City

Little Rock

State/Province

Arkansas

ZIP/Postal Code

72205

Country

United States

Facility Name

GSK Investigational Site

City

Little Rock

State/Province

Arkansas

ZIP/Postal Code

72209

Country

United States

Facility Name

GSK Investigational Site

City

Alhambra

State/Province

California

ZIP/Postal Code

91801

Country

United States

Facility Name

GSK Investigational Site

City

Bakersfield

State/Province

California

ZIP/Postal Code

93301

Country

United States

Facility Name

GSK Investigational Site

City

Canoga Park

State/Province

California

ZIP/Postal Code

91306

Country

United States

Facility Name

GSK Investigational Site

City

Dinuba

State/Province

California

ZIP/Postal Code

93618

Country

United States

Facility Name

GSK Investigational Site

City

Fresno

State/Province

California

ZIP/Postal Code

93703

Country

United States

Facility Name

GSK Investigational Site

City

Fresno

State/Province

California

ZIP/Postal Code

93720

Country

United States

Facility Name

GSK Investigational Site

City

Gold River

State/Province

California

ZIP/Postal Code

95670

Country

United States

Facility Name

GSK Investigational Site

City

Granada Hills

State/Province

California

ZIP/Postal Code

91344

Country

United States

Facility Name

GSK Investigational Site

City

Harbor City

State/Province

California

ZIP/Postal Code

90710

Country

United States

Facility Name

GSK Investigational Site

City

Huntington Beach

State/Province

California

ZIP/Postal Code

92647

Country

United States

Facility Name

GSK Investigational Site

City

Huntington Park

State/Province

California

ZIP/Postal Code

90255

Country

United States

Facility Name

GSK Investigational Site

City

Long Beach

State/Province

California

ZIP/Postal Code

90807

Country

United States

Facility Name

GSK Investigational Site

City

Long Beach

State/Province

California

ZIP/Postal Code

90808

Country

United States

Facility Name

GSK Investigational Site

City

Long Beach

State/Province

California

ZIP/Postal Code

90813

Country

United States

Facility Name

GSK Investigational Site

City

Los Angeles

State/Province

California

ZIP/Postal Code

90057

Country

United States

Facility Name

GSK Investigational Site

City

Napa

State/Province

California

ZIP/Postal Code

94558

Country

United States

Facility Name

GSK Investigational Site

City

Newport Beach

State/Province

California

ZIP/Postal Code

92660

Country

United States

Facility Name

GSK Investigational Site

City

Newport Beach

State/Province

California

ZIP/Postal Code

92663

Country

United States

Facility Name

GSK Investigational Site

City

Oakland

State/Province

California

ZIP/Postal Code

94609

Country

United States

Facility Name

GSK Investigational Site

City

Orange

State/Province

California

ZIP/Postal Code

92868

Country

United States

Facility Name

GSK Investigational Site

City

Palmdale

State/Province

California

ZIP/Postal Code

93551

Country

United States

Facility Name

GSK Investigational Site

City

Paramount

State/Province

California

ZIP/Postal Code

90723

Country

United States

Facility Name

GSK Investigational Site

City

Riverside

State/Province

California

ZIP/Postal Code

92501

Country

United States

Facility Name

GSK Investigational Site

City

Rolling Hills Est.

State/Province

California

ZIP/Postal Code

920274

Country

United States

Facility Name

GSK Investigational Site

City

Rolling Hills Estates

State/Province

California

ZIP/Postal Code

90274

Country

United States

Facility Name

GSK Investigational Site

City

Roseville

State/Province

California

ZIP/Postal Code

95678

Country

United States

Facility Name

GSK Investigational Site

City

Sacramento

State/Province

California

ZIP/Postal Code

95825

Country

United States

Facility Name

GSK Investigational Site

City

San Marino

State/Province

California

ZIP/Postal Code

91108

Country

United States

Facility Name

GSK Investigational Site

City

Santa Monica

State/Province

California

ZIP/Postal Code

90404

Country

United States

Facility Name

GSK Investigational Site

City

West Covina

State/Province

California

ZIP/Postal Code

91790

Country

United States

Facility Name

GSK Investigational Site

City

West Sacramento

State/Province

California

ZIP/Postal Code

95691

Country

United States

Facility Name

GSK Investigational Site

City

Aurora

State/Province

Colorado

ZIP/Postal Code

80045

Country

United States

Facility Name

GSK Investigational Site

City

Centennial

State/Province

Colorado

ZIP/Postal Code

80112

Country

United States

Facility Name

GSK Investigational Site

City

Colorado Springs

State/Province

Colorado

ZIP/Postal Code

80907

Country

United States

Facility Name

GSK Investigational Site

City

Colorado Springs

State/Province

Colorado

ZIP/Postal Code

80920

Country

United States

Facility Name

GSK Investigational Site

City

Colorado Springs

State/Province

Colorado

ZIP/Postal Code

80922

Country

United States

Facility Name

GSK Investigational Site

City

Denver

State/Province

Colorado

ZIP/Postal Code

80206

Country

United States

Facility Name

GSK Investigational Site

City

Waterbury

State/Province

Connecticut

ZIP/Postal Code

06708

Country

United States

Facility Name

GSK Investigational Site

City

Washington

State/Province

District of Columbia

ZIP/Postal Code

20037

Country

United States

Facility Name

GSK Investigational Site

City

Aventura

State/Province

Florida

ZIP/Postal Code

33180

Country

United States

Facility Name

GSK Investigational Site

City

Boynton Beach

State/Province

Florida

ZIP/Postal Code

33435

Country

United States

Facility Name

GSK Investigational Site

City

Cocoa

State/Province

Florida

ZIP/Postal Code

32927

Country

United States

Facility Name

GSK Investigational Site

City

Coral Gables

State/Province

Florida

ZIP/Postal Code

33134

Country

United States

Facility Name

GSK Investigational Site

City

Destin

State/Province

Florida

ZIP/Postal Code

32541

Country

United States

Facility Name

GSK Investigational Site

City

Doral

State/Province

Florida

ZIP/Postal Code

33172

Country

United States

Facility Name

GSK Investigational Site

City

Gainesville

State/Province

Florida

ZIP/Postal Code

32605

Country

United States

Facility Name

GSK Investigational Site

City

Gainesville

State/Province

Florida

ZIP/Postal Code

32610

Country

United States

Facility Name

GSK Investigational Site

City

Hialeah

State/Province

Florida

ZIP/Postal Code

33012

Country

United States

Facility Name

GSK Investigational Site

City

Melbourne

State/Province

Florida

ZIP/Postal Code

32935

Country

United States

Facility Name

GSK Investigational Site

City

Miami Lakes

State/Province

Florida

ZIP/Postal Code

33016

Country

United States

Facility Name

GSK Investigational Site

City

Miami

State/Province

Florida

ZIP/Postal Code

33126

Country

United States

Facility Name

GSK Investigational Site

City

Miami

State/Province

Florida

ZIP/Postal Code

33135

Country

United States

Facility Name

GSK Investigational Site

City

Miami

State/Province

Florida

ZIP/Postal Code

33142

Country

United States

Facility Name

GSK Investigational Site

City

Miami

State/Province

Florida

ZIP/Postal Code

33144

Country

United States

Facility Name

GSK Investigational Site

City

Miami

State/Province

Florida

ZIP/Postal Code

33156

Country

United States

Facility Name

GSK Investigational Site

City

Miami

State/Province

Florida

ZIP/Postal Code

33173

Country

United States

Facility Name

GSK Investigational Site

City

Miami

State/Province

Florida

ZIP/Postal Code

33175

Country

United States

Facility Name

GSK Investigational Site

City

Miami

State/Province

Florida

ZIP/Postal Code

33176

Country

United States

Facility Name

GSK Investigational Site

City

Miami

State/Province

Florida

ZIP/Postal Code

33184

Country

United States

Facility Name

GSK Investigational Site

City

Naples

State/Province

Florida

ZIP/Postal Code

34102

Country

United States

Facility Name

GSK Investigational Site

City

New Port Richey

State/Province

Florida

ZIP/Postal Code

34652

Country

United States

Facility Name

GSK Investigational Site

City

Ocala

State/Province

Florida

ZIP/Postal Code

34471

Country

United States

Facility Name

GSK Investigational Site

City

Orlando

State/Province

Florida

ZIP/Postal Code

32806

Country

United States

Facility Name

GSK Investigational Site

City

Orlando

State/Province

Florida

ZIP/Postal Code

32811

Country

United States

Facility Name

GSK Investigational Site

City

Orlando

State/Province

Florida

ZIP/Postal Code

32822

Country

United States

Facility Name

GSK Investigational Site

City

Pace

State/Province

Florida

ZIP/Postal Code

32571

Country

United States

Facility Name

GSK Investigational Site

City

Pensacola

State/Province

Florida

ZIP/Postal Code

32503

Country

United States

Facility Name

GSK Investigational Site

City

Pensacola

State/Province

Florida

ZIP/Postal Code

32514

Country

United States

Facility Name

GSK Investigational Site

City

Ponte Vedra Beach

State/Province

Florida

ZIP/Postal Code

32081

Country

United States

Facility Name

GSK Investigational Site

City

Saint Cloud

State/Province

Florida

ZIP/Postal Code

34769

Country

United States

Facility Name

GSK Investigational Site

City

Saint Petersburg

State/Province

Florida

ZIP/Postal Code

33701

Country

United States

Facility Name

GSK Investigational Site

City

Saint Petersburg

State/Province

Florida

ZIP/Postal Code

33710

Country

United States

Facility Name

GSK Investigational Site

City

Tampa

State/Province

Florida

ZIP/Postal Code

33606

Country

United States

Facility Name

GSK Investigational Site

City

Tampa

State/Province

Florida

ZIP/Postal Code

33613

Country

United States

Facility Name

GSK Investigational Site

City

Wellington

State/Province

Florida

ZIP/Postal Code

33414

Country

United States

Facility Name

GSK Investigational Site

City

Augusta

State/Province

Georgia

ZIP/Postal Code

30909

Country

United States

Facility Name

GSK Investigational Site

City

Calhoun

State/Province

Georgia

ZIP/Postal Code

30701

Country

United States

Facility Name

GSK Investigational Site

City

Columbus

State/Province

Georgia

ZIP/Postal Code

31904

Country

United States

Facility Name

GSK Investigational Site

City

Gainesville

State/Province

Georgia

ZIP/Postal Code

30501

Country

United States

Facility Name

GSK Investigational Site

City

Lawrenceville

State/Province

Georgia

ZIP/Postal Code

30045

Country

United States

Facility Name

GSK Investigational Site

City

Lilburn

State/Province

Georgia

ZIP/Postal Code

30047

Country

United States

Facility Name

GSK Investigational Site

City

Savannah

State/Province

Georgia

ZIP/Postal Code

31406

Country

United States

Facility Name

GSK Investigational Site

City

Stockbridge

State/Province

Georgia

ZIP/Postal Code

30281

Country

United States

Facility Name

GSK Investigational Site

City

Chicago

State/Province

Illinois

ZIP/Postal Code

60616

Country

United States

Facility Name

GSK Investigational Site

City

Evergreen Park

State/Province

Illinois

ZIP/Postal Code

60805

Country

United States

Facility Name

GSK Investigational Site

City

Glenview

State/Province

Illinois

ZIP/Postal Code

60025

Country

United States

Facility Name

GSK Investigational Site

City

Normal

State/Province

Illinois

ZIP/Postal Code

61761

Country

United States

Facility Name

GSK Investigational Site

City

Shiloh

State/Province

Illinois

ZIP/Postal Code

62269

Country

United States

Facility Name

GSK Investigational Site

City

Crown Point

State/Province

Indiana

ZIP/Postal Code

46307

Country

United States

Facility Name

GSK Investigational Site

City

Evansville

State/Province

Indiana

ZIP/Postal Code

47713

Country

United States

Facility Name

GSK Investigational Site

City

Evansville

State/Province

Indiana

ZIP/Postal Code

47714

Country

United States

Facility Name

GSK Investigational Site

City

Indianapolis

State/Province

Indiana

ZIP/Postal Code

46202

Country

United States

Facility Name

GSK Investigational Site

City

Indianapolis

State/Province

Indiana

ZIP/Postal Code

46208

Country

United States

Facility Name

GSK Investigational Site

City

Indianapolis

State/Province

Indiana

ZIP/Postal Code

46256

Country

United States

Facility Name

GSK Investigational Site

City

West Des Moines

State/Province

Iowa

ZIP/Postal Code

50265

Country

United States

Facility Name

GSK Investigational Site

City

Overland Park

State/Province

Kansas

ZIP/Postal Code

66210

Country

United States

Facility Name

GSK Investigational Site

City

Lexington

State/Province

Kentucky

ZIP/Postal Code

40508

Country

United States

Facility Name

GSK Investigational Site

City

Lexington

State/Province

Kentucky

ZIP/Postal Code

40509

Country

United States

Facility Name

GSK Investigational Site

City

Louisville

State/Province

Kentucky

ZIP/Postal Code

40291

Country

United States

Facility Name

GSK Investigational Site

City

Owensboro

State/Province

Kentucky

ZIP/Postal Code

42301

Country

United States

Facility Name

GSK Investigational Site

City

Metairie

State/Province

Louisiana

ZIP/Postal Code

70006

Country

United States

Facility Name

GSK Investigational Site

City

Shreveport

State/Province

Louisiana

ZIP/Postal Code

71106

Country

United States

Facility Name

GSK Investigational Site

City

Bangor

State/Province

Maine

ZIP/Postal Code

04401

Country

United States

Facility Name

GSK Investigational Site

City

Largo

State/Province

Maryland

ZIP/Postal Code

20774

Country

United States

Facility Name

GSK Investigational Site

City

Silver Spring

State/Province

Maryland

ZIP/Postal Code

20910

Country

United States

Facility Name

GSK Investigational Site

City

White Marsh

State/Province

Maryland

ZIP/Postal Code

21162

Country

United States

Facility Name

GSK Investigational Site

City

Fall River

State/Province

Massachusetts

ZIP/Postal Code

02720

Country

United States

Facility Name

GSK Investigational Site

City

Buckley

State/Province

Michigan

ZIP/Postal Code

49620

Country

United States

Facility Name

GSK Investigational Site

City

Fenton

State/Province

Michigan

ZIP/Postal Code

48430

Country

United States

Facility Name

GSK Investigational Site

City

Niles

State/Province

Michigan

ZIP/Postal Code

49120

Country

United States

Facility Name

GSK Investigational Site

City

Stevensville

State/Province

Michigan

ZIP/Postal Code

49127

Country

United States

Facility Name

GSK Investigational Site

City

Ypsilanti

State/Province

Michigan

ZIP/Postal Code

48197

Country

United States

Facility Name

GSK Investigational Site

City

Plymouth

State/Province

Minnesota

ZIP/Postal Code

55441

Country

United States

Facility Name

GSK Investigational Site

City

Port Gibson

State/Province

Mississippi

ZIP/Postal Code

39150

Country

United States

Facility Name

GSK Investigational Site

City

Kansas City

State/Province

Missouri

ZIP/Postal Code

64108

Country

United States

Facility Name

GSK Investigational Site

City

Kansas City

State/Province

Missouri

ZIP/Postal Code

64114

Country

United States

Facility Name

GSK Investigational Site

City

Kansas City

State/Province

Missouri

ZIP/Postal Code

64138

Country

United States

Facility Name

GSK Investigational Site

City

Warrensburg

State/Province

Missouri

ZIP/Postal Code

64093

Country

United States

Facility Name

GSK Investigational Site

City

Billings

State/Province

Montana

ZIP/Postal Code

59101

Country

United States

Facility Name

GSK Investigational Site

City

Great Falls

State/Province

Montana

ZIP/Postal Code

59405

Country

United States

Facility Name

GSK Investigational Site

City

Missoula

State/Province

Montana

ZIP/Postal Code

59808

Country

United States

Facility Name

GSK Investigational Site

City

Bellevue

State/Province

Nebraska

ZIP/Postal Code

68005

Country

United States

Facility Name

GSK Investigational Site

City

Bellevue

State/Province

Nebraska

ZIP/Postal Code

68123-4303

Country

United States

Facility Name

GSK Investigational Site

City

Lincoln

State/Province

Nebraska

ZIP/Postal Code

68516

Country

United States

Facility Name

GSK Investigational Site

City

Omaha

State/Province

Nebraska

ZIP/Postal Code

68130

Country

United States

Facility Name

GSK Investigational Site

City

Las Vegas

State/Province

Nevada

ZIP/Postal Code

89106

Country

United States

Facility Name

GSK Investigational Site

City

Las Vegas

State/Province

Nevada

ZIP/Postal Code

89107

Country

United States

Facility Name

GSK Investigational Site

City

Brick

State/Province

New Jersey

ZIP/Postal Code

8724

Country

United States

Facility Name

GSK Investigational Site

City

Edison

State/Province

New Jersey

ZIP/Postal Code

08817

Country

United States

Facility Name

GSK Investigational Site

City

Edison

State/Province

New Jersey

ZIP/Postal Code

08820

Country

United States

Facility Name

GSK Investigational Site

City

Livingston

State/Province

New Jersey

ZIP/Postal Code

07039

Country

United States

Facility Name

GSK Investigational Site

City

Marlton

State/Province

New Jersey

ZIP/Postal Code

08053

Country

United States

Facility Name

GSK Investigational Site

City

Northfield

State/Province

New Jersey

ZIP/Postal Code

8225

Country

United States

Facility Name

GSK Investigational Site

City

Ocean City

State/Province

New Jersey

ZIP/Postal Code

07712

Country

United States

Facility Name

GSK Investigational Site

City

Somerville

State/Province

New Jersey

ZIP/Postal Code

8876

Country

United States

Facility Name

GSK Investigational Site

City

Verona

State/Province

New Jersey

ZIP/Postal Code

07044

Country

United States

Facility Name

GSK Investigational Site

City

Albuquerque

State/Province

New Mexico

ZIP/Postal Code

87109

Country

United States

Facility Name

GSK Investigational Site

City

Albuquerque

State/Province

New Mexico

ZIP/Postal Code

87131

Country

United States

Facility Name

GSK Investigational Site

City

Astoria

State/Province

New York

ZIP/Postal Code

11103

Country

United States

Facility Name

GSK Investigational Site

City

Bronx

State/Province

New York

ZIP/Postal Code

10461

Country

United States

Facility Name

GSK Investigational Site

City

Great Neck

State/Province

New York

ZIP/Postal Code

11023

Country

United States

Facility Name

GSK Investigational Site

City

Johnson City

State/Province

New York

ZIP/Postal Code

13790

Country

United States

Facility Name

GSK Investigational Site

City

Newburgh

State/Province

New York

ZIP/Postal Code

12550

Country

United States

Facility Name

GSK Investigational Site

City

North Syracuse

State/Province

New York

ZIP/Postal Code

13212

Country

United States

Facility Name

GSK Investigational Site

City

Staten Island

State/Province

New York

ZIP/Postal Code

10304

Country

United States

Facility Name

GSK Investigational Site

City

Utica

State/Province

New York

ZIP/Postal Code

13502

Country

United States

Facility Name

GSK Investigational Site

City

Westfield

State/Province

New York

ZIP/Postal Code

14787

Country

United States

Facility Name

GSK Investigational Site

City

Asheboro

State/Province

North Carolina

ZIP/Postal Code

27203

Country

United States

Facility Name

GSK Investigational Site

City

Asheville

State/Province

North Carolina

ZIP/Postal Code

28801

Country

United States

Facility Name

GSK Investigational Site

City

Clyde

State/Province

North Carolina

ZIP/Postal Code

28721

Country

United States

Facility Name

GSK Investigational Site

City

High Point

State/Province

North Carolina

ZIP/Postal Code

27262

Country

United States

Facility Name

GSK Investigational Site

City

Shelby

State/Province

North Carolina

ZIP/Postal Code

28152

Country

United States

Facility Name

GSK Investigational Site

City

Fargo

State/Province

North Dakota

ZIP/Postal Code

58104

Country

United States

Facility Name

GSK Investigational Site

City

Akron

State/Province

Ohio

ZIP/Postal Code

44308-1062

Country

United States

Facility Name

GSK Investigational Site

City

Beavercreek

State/Province

Ohio

ZIP/Postal Code

45431

Country

United States

Facility Name

GSK Investigational Site

City

Canton

State/Province

Ohio

ZIP/Postal Code

44718

Country

United States

Facility Name

GSK Investigational Site

City

Centerville

State/Province

Ohio

ZIP/Postal Code

45458

Country

United States

Facility Name

GSK Investigational Site

City

Cincinnati

State/Province

Ohio

ZIP/Postal Code

45231

Country

United States

Facility Name

GSK Investigational Site

City

Cleveland

State/Province

Ohio

ZIP/Postal Code

44130

Country

United States

Facility Name

GSK Investigational Site

City

Dayton

State/Province

Ohio

ZIP/Postal Code

45406

Country

United States

Facility Name

GSK Investigational Site

City

Dayton

State/Province

Ohio

ZIP/Postal Code

45432

Country

United States

Facility Name

GSK Investigational Site

City

Marion

State/Province

Ohio

ZIP/Postal Code

43302

Country

United States

Facility Name

GSK Investigational Site

City

Shaker Heights

State/Province

Ohio

ZIP/Postal Code

44120

Country

United States

Facility Name

GSK Investigational Site

City

Sylvania

State/Province

Ohio

ZIP/Postal Code

43560

Country

United States

Facility Name

GSK Investigational Site

City

Toledo

State/Province

Ohio

ZIP/Postal Code

43606

Country

United States

Facility Name

GSK Investigational Site

City

Toledo

State/Province

Ohio

ZIP/Postal Code

43617

Country

United States

Facility Name

GSK Investigational Site

City

Wheeling

State/Province

Ohio

ZIP/Postal Code

26003

Country

United States

Facility Name

GSK Investigational Site

City

Zanesville

State/Province

Ohio

ZIP/Postal Code

43701

Country

United States

Facility Name

GSK Investigational Site

City

Oklahoma City

State/Province

Oklahoma

ZIP/Postal Code

73112

Country

United States

Facility Name

GSK Investigational Site

City

Oklahoma City

State/Province

Oklahoma

ZIP/Postal Code

73120

Country

United States

Facility Name

GSK Investigational Site

City

Oklahoma City

State/Province

Oklahoma

ZIP/Postal Code

73131

Country

United States

Facility Name

GSK Investigational Site

City

Ashland

State/Province

Oregon

ZIP/Postal Code

97520

Country

United States

Facility Name

GSK Investigational Site

City

Gresham

State/Province

Oregon

ZIP/Postal Code

97030

Country

United States

Facility Name

GSK Investigational Site

City

Lake Oswego

State/Province

Oregon

ZIP/Postal Code

97035

Country

United States

Facility Name

GSK Investigational Site

City

Belle Vernon

State/Province

Pennsylvania

ZIP/Postal Code

15012

Country

United States

Facility Name

GSK Investigational Site

City

Blue Bell

State/Province

Pennsylvania

ZIP/Postal Code

19422

Country

United States

Facility Name

GSK Investigational Site

City

Johnstown

State/Province

Pennsylvania

ZIP/Postal Code

15904

Country

United States

Facility Name

GSK Investigational Site

City

Latrobe

State/Province

Pennsylvania

ZIP/Postal Code

15650

Country

United States

Facility Name

GSK Investigational Site

City

Pittsburgh

State/Province

Pennsylvania

ZIP/Postal Code

15212

Country

United States

Facility Name

GSK Investigational Site

City

Shippensburg

State/Province

Pennsylvania

ZIP/Postal Code

17257

Country

United States

Facility Name

GSK Investigational Site

City

Lincoln

State/Province

Rhode Island

ZIP/Postal Code

2865

Country

United States

Facility Name

GSK Investigational Site

City

Charleston

State/Province

South Carolina

ZIP/Postal Code

29406

Country

United States

Facility Name

GSK Investigational Site

City

Charleston

State/Province

South Carolina

ZIP/Postal Code

29407

Country

United States

Facility Name

GSK Investigational Site

City

Columbia

State/Province

South Carolina

ZIP/Postal Code

29203

Country

United States

Facility Name

GSK Investigational Site

City

Fort Mill

State/Province

South Carolina

ZIP/Postal Code

29707

Country

United States

Facility Name

GSK Investigational Site

City

Greenville

State/Province

South Carolina

ZIP/Postal Code

29607

Country

United States

Facility Name

GSK Investigational Site

City

Chattanooga

State/Province

Tennessee

ZIP/Postal Code

37411

Country

United States

Facility Name

GSK Investigational Site

City

Chattanooga

State/Province

Tennessee

ZIP/Postal Code

37421

Country

United States

Facility Name

GSK Investigational Site

City

Germantown

State/Province

Tennessee

ZIP/Postal Code

38138

Country

United States

Facility Name

GSK Investigational Site

City

McKenzie

State/Province

Tennessee

ZIP/Postal Code

38201

Country

United States

Facility Name

GSK Investigational Site

City

Nashville

State/Province

Tennessee

ZIP/Postal Code

37203

Country

United States

Facility Name

GSK Investigational Site

City

Nashville

State/Province

Tennessee

ZIP/Postal Code

37214

Country

United States

Facility Name

GSK Investigational Site

City

Shelbyville

State/Province

Tennessee

ZIP/Postal Code

37160

Country

United States

Facility Name

GSK Investigational Site

City

Allen

State/Province

Texas

ZIP/Postal Code

75013

Country

United States

Facility Name

GSK Investigational Site

City

Arlington

State/Province

Texas

ZIP/Postal Code

76018

Country

United States

Facility Name

GSK Investigational Site

City

Austin

State/Province

Texas

ZIP/Postal Code

78759-8950

Country

United States

Facility Name

GSK Investigational Site

City

Corsicana

State/Province

Texas

ZIP/Postal Code

75110

Country

United States

Facility Name

GSK Investigational Site

City

Dallas

State/Province

Texas

ZIP/Postal Code

75225

Country

United States

Facility Name

GSK Investigational Site

City

Dallas

State/Province

Texas

ZIP/Postal Code

75230

Country

United States

Facility Name

GSK Investigational Site

City

Dallas

State/Province

Texas

ZIP/Postal Code

75246

Country

United States

Facility Name

GSK Investigational Site

City

Dickinson

State/Province

Texas

ZIP/Postal Code

77539

Country

United States

Facility Name

GSK Investigational Site

City

Duncanville

State/Province

Texas

ZIP/Postal Code

75116

Country

United States

Facility Name

GSK Investigational Site

City

El Paso

State/Province

Texas

ZIP/Postal Code

79925

Country

United States

Facility Name

GSK Investigational Site

City

Gun Barrel City

State/Province

Texas

ZIP/Postal Code

75156

Country

United States

Facility Name

GSK Investigational Site

City

Houston

State/Province

Texas

ZIP/Postal Code

77036

Country

United States

Facility Name

GSK Investigational Site

City

Houston

State/Province

Texas

ZIP/Postal Code

77055

Country

United States

Facility Name

GSK Investigational Site

City

Houston

State/Province

Texas

ZIP/Postal Code

77077

Country

United States

Facility Name

GSK Investigational Site

City

Irving

State/Province

Texas

ZIP/Postal Code

75039

Country

United States

Facility Name

GSK Investigational Site

City

Katy

State/Province

Texas

ZIP/Postal Code

77450

Country

United States

Facility Name

GSK Investigational Site

City

Killeen

State/Province

Texas

ZIP/Postal Code

76542

Country

United States

Facility Name

GSK Investigational Site

City

Kingwood

State/Province

Texas

ZIP/Postal Code

77339

Country

United States

Facility Name

GSK Investigational Site

City

Lewisville

State/Province

Texas

ZIP/Postal Code

75067

Country

United States

Facility Name

GSK Investigational Site

City

Live Oak

State/Province

Texas

ZIP/Postal Code

78233

Country

United States

Facility Name

GSK Investigational Site

City

Lufkin

State/Province

Texas

ZIP/Postal Code

75904

Country

United States

Facility Name

GSK Investigational Site

City

San Antonio

State/Province

Texas

ZIP/Postal Code

78207

Country

United States

Facility Name

GSK Investigational Site

City

San Antonio

State/Province

Texas

ZIP/Postal Code

78224

Country

United States

Facility Name

GSK Investigational Site

City

San Antonio

State/Province

Texas

ZIP/Postal Code

78228

Country

United States

Facility Name

GSK Investigational Site

City

San Antonio

State/Province

Texas

ZIP/Postal Code

78229

Country

United States

Facility Name

GSK Investigational Site

City

San Antonio

State/Province

Texas

ZIP/Postal Code

78251

Country

United States

Facility Name

GSK Investigational Site

City

San Antonio

State/Province

Texas

ZIP/Postal Code

78299

Country

United States

Facility Name

GSK Investigational Site

City

Sealy

State/Province

Texas

ZIP/Postal Code

77474

Country

United States

Facility Name

GSK Investigational Site

City

Sugar Land

State/Province

Texas

ZIP/Postal Code

77478

Country

United States

Facility Name

GSK Investigational Site

City

Sugar Land

State/Province

Texas

ZIP/Postal Code

77479

Country

United States

Facility Name

GSK Investigational Site

City

Tomball

State/Province

Texas

ZIP/Postal Code

77375

Country

United States

Facility Name

GSK Investigational Site

City

Tyler

State/Province

Texas

ZIP/Postal Code

75708

Country

United States

Facility Name

GSK Investigational Site

City

Waco

State/Province

Texas

ZIP/Postal Code

76710

Country

United States

Facility Name

GSK Investigational Site

City

Waco

State/Province

Texas

ZIP/Postal Code

76712

Country

United States

Facility Name

GSK Investigational Site

City

Waxahachie

State/Province

Texas

ZIP/Postal Code

75165

Country

United States

Facility Name

GSK Investigational Site

City

Clinton

State/Province

Utah

ZIP/Postal Code

84015

Country

United States

Facility Name

GSK Investigational Site

City

Draper

State/Province

Utah

ZIP/Postal Code

84020

Country

United States

Facility Name

GSK Investigational Site

City

Layton

State/Province

Utah

ZIP/Postal Code

84041

Country

United States

Facility Name

GSK Investigational Site

City

Murray

State/Province

Utah

ZIP/Postal Code

84107

Country

United States

Facility Name

GSK Investigational Site

City

Woods Cross

State/Province

Utah

ZIP/Postal Code

84087

Country

United States

Facility Name

GSK Investigational Site

City

Charlottesville

State/Province

Virginia

ZIP/Postal Code

22902

Country

United States

Facility Name

GSK Investigational Site

City

Hampton

State/Province

Virginia

ZIP/Postal Code

23666

Country

United States

Facility Name

GSK Investigational Site

City

Midlothian

State/Province

Virginia

ZIP/Postal Code

23113

Country

United States

Facility Name

GSK Investigational Site

City

Midlothian

State/Province

Virginia

ZIP/Postal Code

23114

Country

United States

Facility Name

GSK Investigational Site

City

Norfolk

State/Province

Virginia

ZIP/Postal Code

23507

Country

United States

Facility Name

GSK Investigational Site

City

Richmond

State/Province

Virginia

ZIP/Postal Code

23223

Country

United States

Facility Name

GSK Investigational Site

City

Richmond

State/Province

Virginia

ZIP/Postal Code

23226

Country

United States

Facility Name

GSK Investigational Site

City

Richmond

State/Province

Virginia

ZIP/Postal Code

23235

Country

United States

Facility Name

GSK Investigational Site

City

Virginia Beach

State/Province

Virginia

ZIP/Postal Code

23454

Country

United States

Facility Name

GSK Investigational Site

City

Bellingham

State/Province

Washington

ZIP/Postal Code

98225

Country

United States

Facility Name

GSK Investigational Site

City

Puyallup

State/Province

Washington

ZIP/Postal Code

98371

Country

United States

Facility Name

GSK Investigational Site

City

Wenatchee

State/Province

Washington

ZIP/Postal Code

98801

Country

United States

Facility Name

GSK Investigational Site

City

Greenfield

State/Province

Wisconsin

ZIP/Postal Code

53228

Country

United States

Facility Name

GSK Investigational Site

City

La Crosse

State/Province

Wisconsin

ZIP/Postal Code

54601

Country

United States

Facility Name

GSK Investigational Site

City

Madison

State/Province

Wisconsin

ZIP/Postal Code

53792-9988

Country

United States

Facility Name

GSK Investigational Site

City

Milwaukee

State/Province

Wisconsin

ZIP/Postal Code

53226

Country

United States

Facility Name

GSK Investigational Site

City

Ciudad Autonoma de Buenos Aires

State/Province

Buenos Aires

ZIP/Postal Code

C1122AAK

Country

Argentina

Facility Name

GSK Investigational Site

City

Mar del Plata

State/Province

Buenos Aires

ZIP/Postal Code

7600

Country

Argentina

Facility Name

GSK Investigational Site

City

Nueve de Julio

State/Province

Buenos Aires

ZIP/Postal Code

B6500BWQ

Country

Argentina

Facility Name

GSK Investigational Site

City

Concepcion del Uruguay

State/Province

Entre Ríos

ZIP/Postal Code

3260

Country

Argentina

Facility Name

GSK Investigational Site

City

Parana

State/Province

Entre Ríos

ZIP/Postal Code

E3100BHK

Country

Argentina

Facility Name

GSK Investigational Site

City

Buenos Aires

ZIP/Postal Code

1425

Country

Argentina

Facility Name

GSK Investigational Site

City

Buenos Aires

ZIP/Postal Code

7000

Country

Argentina

Facility Name

GSK Investigational Site

City

Buenos Aires

ZIP/Postal Code

C1425BEN

Country

Argentina

Facility Name

GSK Investigational Site

City

Capital Federal

ZIP/Postal Code

C1270AAN

Country

Argentina

Facility Name

GSK Investigational Site

City

Ciudad Autónoma de Buenos Aires

ZIP/Postal Code

1425

Country

Argentina

Facility Name

GSK Investigational Site

City

Ciudad Autónoma de Buenos Aires

ZIP/Postal Code

C1121ABE

Country

Argentina

Facility Name

GSK Investigational Site

City

Lanús

ZIP/Postal Code

B1824KAJ

Country

Argentina

Facility Name

GSK Investigational Site

City

San Miguel de Tucuman

ZIP/Postal Code

T4000IFL

Country

Argentina

Facility Name

GSK Investigational Site

City

Westmead

State/Province

New South Wales

ZIP/Postal Code

2145

Country

Australia

Facility Name

GSK Investigational Site

City

Auchenflower

State/Province

Queensland

ZIP/Postal Code

4066

Country

Australia

Facility Name

GSK Investigational Site

City

Subiaco

State/Province

Western Australia

ZIP/Postal Code

6008

Country

Australia

Facility Name

GSK Investigational Site

City

Parkville

ZIP/Postal Code

3052

Country

Australia

Facility Name

GSK Investigational Site

City

Randwick

ZIP/Postal Code

2031

Country

Australia

Facility Name

GSK Investigational Site

City

Bregenz

ZIP/Postal Code

A-6900

Country

Austria

Facility Name

GSK Investigational Site

City

Feldkirch

ZIP/Postal Code

6800

Country

Austria

Facility Name

GSK Investigational Site

City

Wien

ZIP/Postal Code

1090

Country

Austria

Facility Name

GSK Investigational Site

City

Antwerpen

ZIP/Postal Code

2018

Country

Belgium

Facility Name

GSK Investigational Site

City

Brussels

ZIP/Postal Code

1090

Country

Belgium

Facility Name

GSK Investigational Site

City

Gembloux

ZIP/Postal Code

5030

Country

Belgium

Facility Name

GSK Investigational Site

City

Hamois (Natoye)

ZIP/Postal Code

5360

Country

Belgium

Facility Name

GSK Investigational Site

City

Leuven

ZIP/Postal Code

3000

Country

Belgium

Facility Name

GSK Investigational Site

City

Blagoevgrad

ZIP/Postal Code

2700

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Pleven

ZIP/Postal Code

5800

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Plovdiv

ZIP/Postal Code

4002

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Ruse

ZIP/Postal Code

7000

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Ruse

ZIP/Postal Code

7002

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Sevlievo

ZIP/Postal Code

5400

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Sofia

ZIP/Postal Code

1431

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Stara Zagora

ZIP/Postal Code

6000

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Varna

ZIP/Postal Code

9000

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Varna

ZIP/Postal Code

9010

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Veliko Tarnovo

ZIP/Postal Code

5000

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Vidin

ZIP/Postal Code

3700

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Brampton

State/Province

Ontario

ZIP/Postal Code

L6T3J1

Country

Canada

Facility Name

GSK Investigational Site

City

Burlington

State/Province

Ontario

ZIP/Postal Code

L7L 0B7

Country

Canada

Facility Name

GSK Investigational Site

City

Oshawa

State/Province

Ontario

ZIP/Postal Code

L1H 7K4

Country

Canada

Facility Name

GSK Investigational Site

City

Toronto

State/Province

Ontario

ZIP/Postal Code

M5T 3A9

Country

Canada

Facility Name

GSK Investigational Site

City

Windsor

State/Province

Ontario

ZIP/Postal Code

N8X 2G1

Country

Canada

Facility Name

GSK Investigational Site

City

Santiago

ZIP/Postal Code

7560994

Country

Chile

Facility Name

GSK Investigational Site

City

Valdivia

ZIP/Postal Code

5090146

Country

Chile

Facility Name

GSK Investigational Site

City

Viña del Mar

ZIP/Postal Code

2570017

Country

Chile

Facility Name

GSK Investigational Site

City

Medellin

Country

Colombia

Facility Name

GSK Investigational Site

City

Cakovec

ZIP/Postal Code

40000

Country

Croatia

Facility Name

GSK Investigational Site

City

Dubrovnik

ZIP/Postal Code

20000

Country

Croatia

Facility Name

GSK Investigational Site

City

Jastrebarsko

ZIP/Postal Code

10450

Country

Croatia

Facility Name

GSK Investigational Site

City

Rijeka

ZIP/Postal Code

51000

Country

Croatia

Facility Name

GSK Investigational Site

City

Split

ZIP/Postal Code

21000

Country

Croatia

Facility Name

GSK Investigational Site

City

Zagreb

ZIP/Postal Code

10000

Country

Croatia

Facility Name

GSK Investigational Site

City

Brno

ZIP/Postal Code

615 00

Country

Czechia

Facility Name

GSK Investigational Site

City

Brno

ZIP/Postal Code

625 00

Country

Czechia

Facility Name

GSK Investigational Site

City

Ceska Lipa

ZIP/Postal Code

470 01

Country

Czechia

Facility Name

GSK Investigational Site

City

Olomouc

ZIP/Postal Code

775 20

Country

Czechia

Facility Name

GSK Investigational Site

City

Praha 4

ZIP/Postal Code

147 00

Country

Czechia

Facility Name

GSK Investigational Site

City

Bruchsal

State/Province

Baden-Wuerttemberg

ZIP/Postal Code

76646

Country

Germany

Facility Name

GSK Investigational Site

City

Mannheim

State/Province

Baden-Wuerttemberg

ZIP/Postal Code

68167

Country

Germany

Facility Name

GSK Investigational Site

City

Augsburg

State/Province

Bayern

ZIP/Postal Code

86150

Country

Germany

Facility Name

GSK Investigational Site

City

Fuerth

State/Province

Bayern

ZIP/Postal Code

90762

Country

Germany

Facility Name

GSK Investigational Site

City

Hoechstadt

State/Province

Bayern

ZIP/Postal Code

91315

Country

Germany

Facility Name

GSK Investigational Site

City

Weissenhorn

State/Province

Bayern

ZIP/Postal Code

89264

Country

Germany

Facility Name

GSK Investigational Site

City

Frankfurt

State/Province

Hessen

ZIP/Postal Code

60590

Country

Germany

Facility Name

GSK Investigational Site

City

Bad Pyrmont

State/Province

Niedersachsen

ZIP/Postal Code

31812

Country

Germany

Facility Name

GSK Investigational Site

City

Bad Lippspringe

State/Province

Nordrhein-Westfalen

ZIP/Postal Code

33175

Country

Germany

Facility Name

GSK Investigational Site

City

Bochum

State/Province

Nordrhein-Westfalen

ZIP/Postal Code

44791

Country

Germany

Facility Name

GSK Investigational Site

City

Detmold

State/Province

Nordrhein-Westfalen

ZIP/Postal Code

32756

Country

Germany

Facility Name

GSK Investigational Site

City

Hagen

State/Province

Nordrhein-Westfalen

ZIP/Postal Code

58089

Country

Germany

Facility Name

GSK Investigational Site

City

Kleve-Materborn

State/Province

Nordrhein-Westfalen

ZIP/Postal Code

47533

Country

Germany

Facility Name

GSK Investigational Site

City

Neuss

State/Province

Nordrhein-Westfalen

ZIP/Postal Code

41469

Country

Germany

Facility Name

GSK Investigational Site

City

Telgte

State/Province

Nordrhein-Westfalen

ZIP/Postal Code

48291

Country

Germany

Facility Name

GSK Investigational Site

City

Teuchern

State/Province

Sachsen-Anhalt

ZIP/Postal Code

6682

Country

Germany

Facility Name

GSK Investigational Site

City

Geesthacht

State/Province

Schleswig-Holstein

ZIP/Postal Code

21502

Country

Germany

Facility Name

GSK Investigational Site

City

Reinfeld

State/Province

Schleswig-Holstein

ZIP/Postal Code

23858

Country

Germany

Facility Name

GSK Investigational Site

City

Berlin

ZIP/Postal Code

12157

Country

Germany

Facility Name

GSK Investigational Site

City

Berlin

ZIP/Postal Code

13353

Country

Germany

Facility Name

GSK Investigational Site

City

Baja

ZIP/Postal Code

6500

Country

Hungary

Facility Name

GSK Investigational Site

City

Budapest

ZIP/Postal Code

1037

Country

Hungary

Facility Name

GSK Investigational Site

City

Budapest

ZIP/Postal Code

1089

Country

Hungary

Facility Name

GSK Investigational Site

City

Budapest

ZIP/Postal Code

1146

Country

Hungary

Facility Name

GSK Investigational Site

City

Miskolc

ZIP/Postal Code

3501

Country

Hungary

Facility Name

GSK Investigational Site

City

Nagykanizsa

ZIP/Postal Code

08800

Country

Hungary

Facility Name

GSK Investigational Site

City

Rackeve

ZIP/Postal Code

2300

Country

Hungary

Facility Name

GSK Investigational Site

City

Szekszárd

ZIP/Postal Code

7100

Country

Hungary

Facility Name

GSK Investigational Site

City

Törökbálint

ZIP/Postal Code

2045

Country

Hungary

Facility Name

GSK Investigational Site

City

Roma

State/Province

Lazio

ZIP/Postal Code

00157

Country

Italy

Facility Name

GSK Investigational Site

City

Milano

State/Province

Lombardia

ZIP/Postal Code

20129

Country

Italy

Facility Name

GSK Investigational Site

City

Brescia

ZIP/Postal Code

25123

Country

Italy

Facility Name

GSK Investigational Site

City

Messina

ZIP/Postal Code

98123

Country

Italy

Facility Name

GSK Investigational Site

City

Milano

ZIP/Postal Code

20142

Country

Italy

Facility Name

GSK Investigational Site

City

Palermo

ZIP/Postal Code

90146

Country

Italy

Facility Name

GSK Investigational Site

City

Roma

ZIP/Postal Code

00168

Country

Italy

Facility Name

GSK Investigational Site

City

Sesto San Giovanni

ZIP/Postal Code

20099

Country

Italy

Facility Name

GSK Investigational Site

City

Cheongju-si

ZIP/Postal Code

361-711

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Gyeonggi-do

ZIP/Postal Code

463-712

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Gyeonggi-do

ZIP/Postal Code

471-020

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Gyeonggi-do

ZIP/Postal Code

480-717

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Incheon

ZIP/Postal Code

400-711

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Pusan

ZIP/Postal Code

612030

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Seoul

ZIP/Postal Code

110-744

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Seoul

ZIP/Postal Code

120-752

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Seoul

ZIP/Postal Code

130-702

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Seoul

ZIP/Postal Code

137-701

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Seoul

ZIP/Postal Code

143-729

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Riga

ZIP/Postal Code

1011

Country

Latvia

Facility Name

GSK Investigational Site

City

Riga

ZIP/Postal Code

1063

Country

Latvia

Facility Name

GSK Investigational Site

City

Riga

ZIP/Postal Code

LV 1003

Country

Latvia

Facility Name

GSK Investigational Site

City

Riga

ZIP/Postal Code

LV 1004

Country

Latvia

Facility Name

GSK Investigational Site

City

Tukums

ZIP/Postal Code

3101

Country

Latvia

Facility Name

GSK Investigational Site

City

Kaunas

ZIP/Postal Code

LT-49449

Country

Lithuania

Facility Name

GSK Investigational Site

City

Kaunas

ZIP/Postal Code

LT-50009

Country

Lithuania

Facility Name

GSK Investigational Site

City

Utena

ZIP/Postal Code

LT-28151

Country

Lithuania

Facility Name

GSK Investigational Site

City

Vilnius

ZIP/Postal Code

LT-04338

Country

Lithuania

Facility Name

GSK Investigational Site

City

Vilnius

ZIP/Postal Code

LT-08406

Country

Lithuania

Facility Name

GSK Investigational Site

City

Ipoh

ZIP/Postal Code

32040

Country

Malaysia

Facility Name

GSK Investigational Site

City

Kuala Lumpur

ZIP/Postal Code

59100

Country

Malaysia

Facility Name

GSK Investigational Site

City

Kuching

ZIP/Postal Code

93586

Country

Malaysia

Facility Name

GSK Investigational Site

City

Seremban, Negeri Sembilan

ZIP/Postal Code

70300

Country

Malaysia

Facility Name

GSK Investigational Site

City

Sibu

ZIP/Postal Code

96000

Country

Malaysia

Facility Name

GSK Investigational Site

City

Sungai Buloh

ZIP/Postal Code

47000

Country

Malaysia

Facility Name

GSK Investigational Site

City

Guadalajara

State/Province

Jalisco

ZIP/Postal Code

44100

Country

Mexico

Facility Name

GSK Investigational Site

City

Monterrey

State/Province

Nuevo León

ZIP/Postal Code

64710

Country

Mexico

Facility Name

GSK Investigational Site

City

Chihuahua

ZIP/Postal Code

31020

Country

Mexico

Facility Name

GSK Investigational Site

City

Huixquilucan

ZIP/Postal Code

52763

Country

Mexico

Facility Name

GSK Investigational Site

City

Monterrey

ZIP/Postal Code

64718

Country

Mexico

Facility Name

GSK Investigational Site

City

Miraflores

State/Province

Lima

ZIP/Postal Code

Country

Peru

Facility Name

GSK Investigational Site

City

San Martin de Porres

State/Province

Lima

ZIP/Postal Code

Lima 31

Country

Peru

Facility Name

GSK Investigational Site

City

Santiago de Surco

State/Province

Lima

ZIP/Postal Code

Lima 33

Country

Peru

Facility Name

GSK Investigational Site

City

Lima

ZIP/Postal Code

Lima 18

Country

Peru

Facility Name

GSK Investigational Site

City

Lima

ZIP/Postal Code

Lima 1

Country

Peru

Facility Name

GSK Investigational Site

City

Lima

ZIP/Postal Code

Lima 27

Country

Peru

Facility Name

GSK Investigational Site

City

San Borja

ZIP/Postal Code

L36

Country

Peru

Facility Name

GSK Investigational Site

City

Dasmariñas, Cavite

ZIP/Postal Code

4114

Country

Philippines

Facility Name

GSK Investigational Site

City

Davao

ZIP/Postal Code

8000

Country

Philippines

Facility Name

GSK Investigational Site

City

Pulilan

ZIP/Postal Code

3005

Country

Philippines

Facility Name

GSK Investigational Site

City

Quezon City

ZIP/Postal Code

1100

Country

Philippines

Facility Name

GSK Investigational Site

City

Quezon City

ZIP/Postal Code

1108

Country

Philippines

Facility Name

GSK Investigational Site

City

Bialystok

ZIP/Postal Code

15-430

Country

Poland

Facility Name

GSK Investigational Site

City

Bialystok

Country

Poland

Facility Name

GSK Investigational Site

City

Cieszyn

ZIP/Postal Code

43-400

Country

Poland

Facility Name

GSK Investigational Site

City

Dębica

ZIP/Postal Code

39 - 200

Country

Poland

Facility Name

GSK Investigational Site

City

Gdanska

ZIP/Postal Code

80-433

Country

Poland

Facility Name

GSK Investigational Site

City

Gdansk

ZIP/Postal Code

80-308

Country

Poland

Facility Name

GSK Investigational Site

City

Gdansk

ZIP/Postal Code

80-462

Country

Poland

Facility Name

GSK Investigational Site

City

Jelenia Gora

ZIP/Postal Code

58-500

Country

Poland

Facility Name

GSK Investigational Site

City

Karpacz

ZIP/Postal Code

58-540

Country

Poland

Facility Name

GSK Investigational Site

City

Koszalin

ZIP/Postal Code

75-729

Country

Poland

Facility Name

GSK Investigational Site

City

Krakow

ZIP/Postal Code

31-023

Country

Poland

Facility Name

GSK Investigational Site

City

Krakow

ZIP/Postal Code

31-503

Country

Poland

Facility Name

GSK Investigational Site

City

Lodz

ZIP/Postal Code

90-553

Country

Poland

Facility Name

GSK Investigational Site

City

Lodz

ZIP/Postal Code

93-513

Country

Poland

Facility Name

GSK Investigational Site

City

Lubin

ZIP/Postal Code

59-300

Country

Poland

Facility Name

GSK Investigational Site

City

Lublin

ZIP/Postal Code

20-093

Country

Poland

Facility Name

GSK Investigational Site

City

Lublin

ZIP/Postal Code

20-552

Country

Poland

Facility Name

GSK Investigational Site

City

Poznan

ZIP/Postal Code

60-214

Country

Poland

Facility Name

GSK Investigational Site

City

Rzeszow

ZIP/Postal Code

35-241

Country

Poland

Facility Name

GSK Investigational Site

City

Sandomierz

ZIP/Postal Code

27-600

Country

Poland

Facility Name

GSK Investigational Site

City

Skarżysko-Kamienna

ZIP/Postal Code

26-110

Country

Poland

Facility Name

GSK Investigational Site

City

Skierniewice

ZIP/Postal Code

96-100

Country

Poland

Facility Name

GSK Investigational Site

City

Szczecin

ZIP/Postal Code

70-382

Country

Poland

Facility Name

GSK Investigational Site

City

Szczecin

ZIP/Postal Code

70-780

Country

Poland

Facility Name

GSK Investigational Site

City

Tarnow

ZIP/Postal Code

33-100

Country

Poland

Facility Name

GSK Investigational Site

City

Warszawa

ZIP/Postal Code

01-157

Country

Poland

Facility Name

GSK Investigational Site

City

Wroclaw

ZIP/Postal Code

50-445

Country

Poland

Facility Name

GSK Investigational Site

City

Wroclaw

ZIP/Postal Code

53-301

Country

Poland

Facility Name

GSK Investigational Site

City

Zabrze

ZIP/Postal Code

41 - 800

Country

Poland

Facility Name

GSK Investigational Site

City

Zabrze

ZIP/Postal Code

41-800

Country

Poland

Facility Name

GSK Investigational Site

City

Bucharest

ZIP/Postal Code

20395

Country

Romania

Facility Name

GSK Investigational Site

City

Sibiu

ZIP/Postal Code

550166

Country

Romania

Facility Name

GSK Investigational Site

City

Moscow

ZIP/Postal Code

119435

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Moscow

ZIP/Postal Code

119991

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Moscow

ZIP/Postal Code

125412

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Nizhniy Novgorod

ZIP/Postal Code

603005

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Novosibirsk

ZIP/Postal Code

630099

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Saint Petersburg

ZIP/Postal Code

192212

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Saint Petersburg

ZIP/Postal Code

196084

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Saint Petersburg

ZIP/Postal Code

196657

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Saratov

ZIP/Postal Code

410028

Country

Russian Federation

Facility Name

GSK Investigational Site

City

St'Petersburg

ZIP/Postal Code

191144

Country

Russian Federation

Facility Name

GSK Investigational Site

City

St. Petersburg

ZIP/Postal Code

194100

Country

Russian Federation

Facility Name

GSK Investigational Site

City

St.Petersburg

ZIP/Postal Code

194100

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Tomsk

ZIP/Postal Code

634 050

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Voronezh

ZIP/Postal Code

394036

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Yaroslavl

ZIP/Postal Code

150003

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Belgrade

ZIP/Postal Code

11000

Country

Serbia

Facility Name

GSK Investigational Site

City

Cacak

ZIP/Postal Code

32000

Country

Serbia

Facility Name

GSK Investigational Site

City

Nis

ZIP/Postal Code

18000

Country

Serbia

Facility Name

GSK Investigational Site

City

Novi Sad

ZIP/Postal Code

21 000

Country

Serbia

Facility Name

GSK Investigational Site

City

Uzice

ZIP/Postal Code

31000

Country

Serbia

Facility Name

GSK Investigational Site

City

Martin

ZIP/Postal Code

036 59

Country

Slovakia

Facility Name

GSK Investigational Site

City

Nitra

ZIP/Postal Code

949 01

Country

Slovakia

Facility Name

GSK Investigational Site

City

Trnava

ZIP/Postal Code

917 01

Country

Slovakia

Facility Name

GSK Investigational Site

City

Welkom

State/Province

Free State

ZIP/Postal Code

9460

Country

South Africa

Facility Name

GSK Investigational Site

City

Benoni

State/Province

Gauteng

ZIP/Postal Code

1501

Country

South Africa

Facility Name

GSK Investigational Site

City

Krugersdorp

State/Province

Gauteng

ZIP/Postal Code

1752

Country

South Africa

Facility Name

GSK Investigational Site

City

Pretoria

State/Province

Gauteng

ZIP/Postal Code

0132

Country

South Africa

Facility Name

GSK Investigational Site

City

Benoni

ZIP/Postal Code

1501

Country

South Africa

Facility Name

GSK Investigational Site

City

Cape Town

ZIP/Postal Code

7441

Country

South Africa

Facility Name

GSK Investigational Site

City

Cape Town

ZIP/Postal Code

7500

Country

South Africa

Facility Name

GSK Investigational Site

City

Cape Town

ZIP/Postal Code

7572

Country

South Africa

Facility Name

GSK Investigational Site

City

Cape Town

ZIP/Postal Code

7700

Country

South Africa

Facility Name

GSK Investigational Site

City

Claremont

ZIP/Postal Code

7708

Country

South Africa

Facility Name

GSK Investigational Site

City

Durban

ZIP/Postal Code

4001

Country

South Africa

Facility Name

GSK Investigational Site

City

Middelburg

ZIP/Postal Code

1501

Country

South Africa

Facility Name

GSK Investigational Site

City

Paarl

ZIP/Postal Code

7646

Country

South Africa

Facility Name

GSK Investigational Site

City

Pretoria

ZIP/Postal Code

0001

Country

South Africa

Facility Name

GSK Investigational Site

City

Pretoria

ZIP/Postal Code

0002

Country

South Africa

Facility Name

GSK Investigational Site

City

Thabazimbi

ZIP/Postal Code

0380

Country

South Africa

Facility Name

GSK Investigational Site

City

Barcelona

ZIP/Postal Code

08022

Country

Spain

Facility Name

GSK Investigational Site

City

Burgos

ZIP/Postal Code

09005

Country

Spain

Facility Name

GSK Investigational Site

City

Madrid

ZIP/Postal Code

28041

Country

Spain

Facility Name

GSK Investigational Site

City

Pozuelo De Alarcón/Madrid

ZIP/Postal Code

28223

Country

Spain

Facility Name

GSK Investigational Site

City

Sabadell (Barcelona)

ZIP/Postal Code

8208

Country

Spain

Facility Name

GSK Investigational Site

City

Valencia

ZIP/Postal Code

46026

Country

Spain

Facility Name

GSK Investigational Site

City

Changhua

ZIP/Postal Code

500

Country

Taiwan

Facility Name

GSK Investigational Site

City

Kaohsiung

ZIP/Postal Code

807

Country

Taiwan

Facility Name

GSK Investigational Site

City

Kaohsiung

ZIP/Postal Code

813

Country

Taiwan

Facility Name

GSK Investigational Site

City

Taichung

ZIP/Postal Code

402

Country

Taiwan

Facility Name

GSK Investigational Site

City

Taichung

ZIP/Postal Code

40447

Country

Taiwan

Facility Name

GSK Investigational Site

City

Taipei

ZIP/Postal Code

100

Country

Taiwan

Facility Name

GSK Investigational Site

City

Taipei

ZIP/Postal Code

11031

Country

Taiwan

Facility Name

GSK Investigational Site

City

Taoyuan

ZIP/Postal Code

333

Country

Taiwan

Facility Name

GSK Investigational Site

City

Bangkoknoi

ZIP/Postal Code

10700

Country

Thailand

Facility Name

GSK Investigational Site

City

Bangkok

ZIP/Postal Code

10330

Country

Thailand

Facility Name

GSK Investigational Site

City

Bangkok

Country

Thailand

Facility Name

GSK Investigational Site

City

Khon Kaen

ZIP/Postal Code

40002

Country

Thailand

Facility Name

GSK Investigational Site

City

Pathumthani

ZIP/Postal Code

12120

Country

Thailand

Facility Name

GSK Investigational Site

City

Phitsanulok

ZIP/Postal Code

65000

Country

Thailand

Facility Name

GSK Investigational Site

City

Ratchatewi

ZIP/Postal Code

10400

Country

Thailand

Facility Name

GSK Investigational Site

City

Dnipropetrovsk

ZIP/Postal Code

49100

Country

Ukraine

Facility Name

GSK Investigational Site

City

Dnipropetrovsk

ZIP/Postal Code

49101

Country

Ukraine

Facility Name

GSK Investigational Site

City

Kharkiv

ZIP/Postal Code

61050

Country

Ukraine

Facility Name

GSK Investigational Site

City

Kharkiv

ZIP/Postal Code

61093

Country

Ukraine

Facility Name

GSK Investigational Site

City

Kryvyi Rih

ZIP/Postal Code

50082

Country

Ukraine

Facility Name

GSK Investigational Site

City

Kyiv

ZIP/Postal Code

4050

Country

Ukraine

Facility Name

GSK Investigational Site

City

Kyiv

Country

Ukraine

Facility Name

GSK Investigational Site

City

Lviv

ZIP/Postal Code

79059

Country

Ukraine

Facility Name

GSK Investigational Site

City

Odesa

ZIP/Postal Code

65031

Country

Ukraine

Facility Name

GSK Investigational Site

City

Odesa

ZIP/Postal Code

65038

Country

Ukraine

Facility Name

GSK Investigational Site

City

Poltava

ZIP/Postal Code

36011

Country

Ukraine

Facility Name

GSK Investigational Site

City

Simferopol

ZIP/Postal Code

95006

Country

Ukraine

Facility Name

GSK Investigational Site

City

Sumy

ZIP/Postal Code

40031

Country

Ukraine

Facility Name

GSK Investigational Site

City

Uzhhorod

ZIP/Postal Code

88009

Country

Ukraine

Facility Name

GSK Investigational Site

City

Zaporizhia

ZIP/Postal Code

69063

Country

Ukraine

Facility Name

GSK Investigational Site

City

Chesterfield

State/Province

Derbyshire

ZIP/Postal Code

S40 4TF

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Cardiff

State/Province

Glamorgan

ZIP/Postal Code

CF5 4AE

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Newcastle Upon Tyne

State/Province

Northumberland

ZIP/Postal Code

NE1 4LP

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Bath

State/Province

Somerset

ZIP/Postal Code

BA2 1NH

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Brighton

State/Province

Sussex East

ZIP/Postal Code

BN2 5BE

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Atherstone

State/Province

Warwickshire

ZIP/Postal Code

CV9 1EU

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Barry

ZIP/Postal Code

CF63 4AR

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Bexhill-on-Sea

ZIP/Postal Code

TN40 1JJ

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Doncaster

ZIP/Postal Code

DN9 2HY

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Glasgow

ZIP/Postal Code

G3 8SJ

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Kent

ZIP/Postal Code

CT5 3QU

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Leicester

ZIP/Postal Code

LE1 5WW

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Macclesfield

ZIP/Postal Code

SK10 3BL

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Merseyside

ZIP/Postal Code

CH41 0DD

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Penzance

ZIP/Postal Code

TK19 7HX

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Peterborough

ZIP/Postal Code

PE8 6PL

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Stockton on Tees

ZIP/Postal Code

TS19 8PE

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Stoke on Trent

ZIP/Postal Code

ST4 6QG

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Surrey

ZIP/Postal Code

RH1 5RH

Country

United Kingdom

12. IPD Sharing Statement

Plan to Share IPD

Yes

IPD Sharing Plan Description

Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.

Citations:

PubMed Identifier

32966707

Citation

Lee LA, Pedersen S, Pascoe SJ, Szefler SJ, Lenney W. No dose effect observed with chronic fluticasone propionate on growth velocity in children. Pediatr Allergy Immunol. 2021 Feb;32(2):377-381. doi: 10.1111/pai.13378. Epub 2020 Oct 26. No abstract available.

Results Reference

derived

PubMed Identifier

27579634

Citation

Stempel DA, Szefler SJ, Pedersen S, Zeiger RS, Yeakey AM, Lee LA, Liu AH, Mitchell H, Kral KM, Raphiou IH, Prillaman BA, Buaron KS, Yun Kirby S, Pascoe SJ; VESTRI Investigators. Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma. N Engl J Med. 2016 Sep 1;375(9):840-9. doi: 10.1056/NEJMoa1606356.

Results Reference

derived

Links:

URL

https://www.clinicalstudydatarequest.com

Description

Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research.

Available IPD and Supporting Information:

Available IPD/Information Type

Individual Participant Data Set

Available IPD/Information URL

https://www.clinicalstudydatarequest.com

Available IPD/Information Identifier

115358

Available IPD/Information Comments

For additional information about this study please refer to the GSK Clinical Study Register

Available IPD/Information Type

Statistical Analysis Plan

Available IPD/Information URL

https://www.clinicalstudydatarequest.com

Available IPD/Information Identifier

115358

Available IPD/Information Comments

For additional information about this study please refer to the GSK Clinical Study Register

Available IPD/Information Type

Study Protocol

Available IPD/Information URL

https://www.clinicalstudydatarequest.com

Available IPD/Information Identifier

115358

Available IPD/Information Comments

For additional information about this study please refer to the GSK Clinical Study Register

Available IPD/Information Type

Dataset Specification

Available IPD/Information URL

https://www.clinicalstudydatarequest.com

Available IPD/Information Identifier

115358

Available IPD/Information Comments

For additional information about this study please refer to the GSK Clinical Study Register

Available IPD/Information Type

Clinical Study Report

Available IPD/Information URL

https://www.clinicalstudydatarequest.com

Available IPD/Information Identifier

115358

Available IPD/Information Comments

For additional information about this study please refer to the GSK Clinical Study Register

Available IPD/Information Type

Informed Consent Form

Available IPD/Information URL

https://www.clinicalstudydatarequest.com

Available IPD/Information Identifier

115358

Available IPD/Information Comments

For additional information about this study please refer to the GSK Clinical Study Register

Available IPD/Information Type

Annotated Case Report Form

Available IPD/Information URL

https://www.clinicalstudydatarequest.com

Available IPD/Information Identifier

115358

Available IPD/Information Comments

For additional information about this study please refer to the GSK Clinical Study Register

Learn more about this trial

6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old

We'll reach out to this number within 24 hrs

6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old (VESTRI)

Asthma

About this trial

Eligibility Criteria

Sites / Locations

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

1. Study Identification

2. Study Status

3. Sponsor/Collaborators

4. Oversight

5. Study Description

6. Conditions and Keywords

7. Study Design

8. Arms, Groups, and Interventions

10. Eligibility

12. IPD Sharing Statement

Learn more about this trial